FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11. FDA Commissioner Dr. Robert Califf says Omicron is making more kids sick and hospitalized. Do you think young children need a third shot?
The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech’s Covid-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
“While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer term effects, even following initially mild disease,” said FDA Commissioner Robert M. Califf, M.D.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11The FDA has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Les mer »
FDA approves Pfizer COVID-19 booster for children ages 5 to 11Pfizer’s COVID-19 booster shot for U.S. kids ages 5 to 11 has been approved by the FDA. Next, it will need the CDC’s final sign-off.
Les mer »
FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11The FDA has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Les mer »
FDA authorizes Pfizer Covid-19 booster shots for children ages 5 to 11The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's Covid-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Les mer »
FDA authorizes Pfizer Covid booster for children 5 to 11 years oldA study in February found that two doses of the vaccine offered little protection against the omicron variant.
Les mer »
FDA Authorizes Pfizer Covid Booster Dose for Kids Ages 5 to 11 Years OldThe Food and Drug Administration on Tuesday authorized a Pfizer booster dose for children ages 5 through 11 years old at least five months after they complete their two-dose primary series. Dr. Peter Marks, head of the FDA division responsible for vaccines, said data increasingly shows that the protection provided by two shots wanes off over time. The FDA determined…
Les mer »